Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Thyroid cancer originates from thyroid tissue and is most common in adults aged 30 to 60. Some patients show no symptoms in the early stage, and missing treatment may lead to local spread or distant metastasis, endangering life. Treatment options must be individualized based on pathological type and stage, and timely treatment is crucial for prognosis.
As an innovative therapy, immune reconstruction cell therapy activates and enhances the patient’s own immune system to fight cancer, effectively clearing residual cancer cells and reducing the risk of recurrence. Its advantages include:
① Targeted killing of cancer cells while avoiding damage to normal tissues;
② Enhancing the patient’s immune surveillance ability, improving long-term anticancer effects;
③ Can be combined with traditional treatments to comprehensively improve therapeutic outcomes.
Immune reconstruction cell therapy is becoming an important part of comprehensive thyroid cancer treatment, especially suitable for advanced or recurrent patients.
In practice, tumor patients undergoing traditional treatments such as surgery and radiotherapy often face impaired immune function, increased risk of infection, and slow recovery. To help patients better endure treatment and improve tolerance and quality of life, different immune reconstruction plans should be scientifically designed in stages.
● Short-term plan: Quickly boost immunity through immune cell reinfusion, enhancing the effectiveness of anticancer treatment.
● Mid-term plan: Reduce side effects of traditional treatments, promote recovery, and support completion of standard regimens.
● Long-term plan: Comprehensive improvement of immunity through immune cell reconstruction, intestinal immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, improving quality of life and extending survival.
1. Surgical Treatment
Surgery is the most common and fundamental treatment for thyroid cancer. By removing part or all of the thyroid gland and affected lymph nodes, the goal of cure can be achieved. With technological progress, minimally invasive surgery such as endoscopic thyroidectomy has become increasingly common, offering smaller wounds and faster recovery. Surgical plans are customized based on cancer type and extent of invasion.
2. Radiation Therapy
Radiation therapy is often used as adjuvant treatment after surgery, or as the main therapy for inoperable patients. The primary method is radioactive iodine-131 therapy, which selectively kills cancer cells by utilizing the iodine uptake characteristic of thyroid cells. In addition, external radiation therapy can control local lesions and relieve symptoms.
3. Targeted Therapy
Targeted therapy works on specific molecular targets of cancer cells, suitable for patients with positive gene mutations or advanced disease. Common drugs include multi-target tyrosine kinase inhibitors, which can effectively delay disease progression and improve quality of life.
4. Minimally Invasive Treatment Methods
In recent years, minimally invasive techniques in thyroid cancer treatment have shown advantages such as less trauma and faster recovery, suitable for patients not fit for surgery or as adjuvant therapy after surgery.
5. Chemotherapy and Comprehensive Treatment
Chemotherapy is rarely used in thyroid cancer, mainly for undifferentiated or drug-resistant advanced cases. It is usually combined with targeted and immunotherapy to enhance efficacy. Comprehensive treatment emphasizes multidisciplinary collaboration to develop individualized plans.
Experts at United Life International Medical Center emphasize that thyroid cancer treatment requires coordinated use of multiple approaches. The addition of immune reconstruction cell therapy brings new hope to patients. Early standardized treatment can effectively extend survival and improve quality of life, so treatment should not be delayed.
